Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Beth Bready"'
Publikováno v:
Anti-Cancer Drugs. 7:728-733
We conducted two consecutive phase I clinical trials to identify the qualitative and quantitative toxic effects of uracil-tegafur (UFT) [Taiho Pharmaceutical Co. Ltd, Tokyo, Japan; (BMS-200604) Bristol-Myers Squibb, Princeton, NJ] administered either
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73e60806695208088b133774a0f6282f
https://doi.org/10.1097/00001813-199609000-00002
https://doi.org/10.1097/00001813-199609000-00002
Autor:
Steven Sugarman, Bernard Levin, Beth Bready, Avi B. Markowitz, Yehuda Z. Patt, Richard Pazdur, Jaffer A. Ajani, Yvonne Lassere, Virginia Rhodes, Dennie V. Jones, James L. Abbruzzese
Publikováno v:
Journal of Clinical Oncology. 12:2296-2300
PURPOSE To determine the activity and evaluate the toxicity of uracil and tegafur in a 4:1 molar concentration (UFT; Taiho Pharmaceutical Ltd, Tokyo, Japan) plus oral calcium leucovorin in the treatment of patients with advanced colorectal carcinoma.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50e847950dac7cdffe451392be156c80
https://doi.org/10.1200/jco.1994.12.11.2296
https://doi.org/10.1200/jco.1994.12.11.2296
Publikováno v:
Journal of Surgical Oncology. 53:127-130
Hepatoblastomas (HBs) and hepatocellular carcinomas (HCCs) constitute the majority of hepatic tumors in children. Although most children who have HB or HQC present with unresectable disease, chemotherapy may reduce the size of the primary tumor and m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b434e838dd2637cec70d81eedcdeb4c
https://doi.org/10.1002/jso.2930530534
https://doi.org/10.1002/jso.2930530534
Autor:
Lawrence A. Trissel, Beth Bready
Publikováno v:
American Journal of Health-System Pharmacy. 49:1716-1719
The compatibility of taxol in 5% dextrose injection with each of 17 other drugs during simulated Y-site injection was studied through visual and turbidimetric assessment. A 4-mL sample of taxol 1.2 mg/mL in 5% dextrose injection was combined with a 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f3f0ff0886f98605b108bfeca154188
https://doi.org/10.1093/ajhp/49.7.1716
https://doi.org/10.1093/ajhp/49.7.1716
Publikováno v:
American Journal of Health-System Pharmacy. 49:402-406
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6d72cb958a5484cb10eb69286073286
https://doi.org/10.1093/ajhp/49.2.402
https://doi.org/10.1093/ajhp/49.2.402
Autor:
James L. Abbruzzese, Dennie V. Jones, Scott M. Lippman, Steve Sugarman, Dennis F. Moore, Beth Bready, Richard Pazdur
Publikováno v:
American Journal of Clinical Oncology. 18:525-527
The combination of interferons (IFNs) and retinoids in antineoplastic therapy is based upon preclinical, in vitro, and in vivo observations. Retinoid-IFN combinations have shown significant antitumor activity against advanced cutaneous and cervical s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::637c10350229c1338b66f438cbfb2b43
https://doi.org/10.1097/00000421-199512000-00013
https://doi.org/10.1097/00000421-199512000-00013
Autor:
Rodger J. Winn, Anthony J. Scalzo, Beth Bready, David R. Close, Richard Pazdur, James E. Brandof, Sharon Kolbye
Publikováno v:
Investigational New Drugs. 12:263-265
Piroxantrone, a synthetic intercalating agent, was studied in patients with advanced, measurable gastric adenocarcinoma who had not received prior chemotherapy. The starting piroxantrone dose was 150 mg/m2 given intravenously over 1 hour on day 1 and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74c95992906b07d876c7897e483712f0
https://doi.org/10.1007/bf00873970
https://doi.org/10.1007/bf00873970
Autor:
William McGarry, Beth Bready, Richard Pazdur, J. Wendall Goodwin, Robert J. Belt, Shaker R. Dakhil, Melanie E. Royce, Rodger J. Winn, Paulo M. Hoff, Richard Gray
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 17(10)
PURPOSE: Several agents have been evaluated for their effect as biochemical modulators of fluorouracil (5-FU) in the treatment of metastatic colorectal carcinoma. In this study, we used folinic acid (FA), N-phosphonacetyl-L-aspartic acid (PALA), and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::989079f31e9ea4a8227fb61a327e4e1e
https://pubmed.ncbi.nlm.nih.gov/10506630
https://pubmed.ncbi.nlm.nih.gov/10506630
Autor:
Rodger J. Winn, James L. Abbruzzese, Dennis F. Moore, Richard Pazdur, Robert J. Belt, Beth Bready, C. Mangold, James L. Wade, Jaffer A. Ajani, D. W. Dubovsky
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 5(3)
Summary Background The methotrexate analogue 10-ethyl-10-deazaaminopterin (10-EdAM, or edatrexate) has shown antitumor activity in preclinical testing and clinical studies of patients with breast, lung and head and neck carcinomas. A phase II study w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d63ae0a9ce4a8d02a34564a7ce046d7
https://pubmed.ncbi.nlm.nih.gov/8186177
https://pubmed.ncbi.nlm.nih.gov/8186177
Autor:
Robert A. Newman, M. Bayssas, Richard Pazdur, Beth Bready, Franzanne Vreeland, Angela Fuentes, John A. Benvenuto, Martin N. Raber, Beverly M. Newman, Dennis Moore, Ishmael Jaiyesimi
Publikováno v:
Journal of the National Cancer Institute. 84(23)
Background Taxotere, a semisynthetic compound structurally related to taxol, has a broad spectrum of activity in murine transplantable tumors; in the B16 melanoma model, it caused a total log cell kill 2.5 times greater than that caused by taxol at e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41cc7507601653171f91446552d77e0d
https://pubmed.ncbi.nlm.nih.gov/1359154
https://pubmed.ncbi.nlm.nih.gov/1359154